Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Theranostics|September 6, 2024
Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patientsPeter H J Slootbeek, María Victoria Luna-Velez, Bastiaan M Privé, et al.
European Urology|December 4, 2012
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancerGisele H J M Leyten, Daphne Hessels, Sander A Jannink, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2025
A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancerBastiaan M Privé, Tim M Govers, Bas Israël, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
International Journal of Cancer|September 23, 2014
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxelMichel D Wissing, Jules L L M Coenen, Pieter van den Berg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily PracticeJoost H H M van Riel, Maarten L Donswijk, Christel Brouwer, et al.
European Urology Oncology|October 31, 2025
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to TherapyKarim Fizazi, Johann S de Bono, A Douglas Laird, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 7, 2019
Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA InitiativeMaarten Cuypers, Hoda H M Al-Itejawi, Cornelia F van Uden-Kraan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate CancerGisele H J M Leyten, Daphne Hessels, Frank P Smit, et al.
Cancers|December 24, 2021
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate CancerEmmy Boerrigter, Guillemette E Benoist, Inge M van Oort, et al.
Pageof 14